register

News & Trends - MedTech & Diagnostics

Surgeons voice concerns over access to General Use Items from Prostheses List

Health Industry Hub | April 5, 2023 |

MedTech News: The Royal Australasian College of Surgeons (RACS) retains the concerns about the removal of ‘general use’ items from the Prostheses List (PL).

In its submission to Prostheses List Reforms – Consultation Paper 5 – Bundling of Benefits for General Use Items, RACS was supported by General Surgeons Australia (GSA) and the Urological Society of Australia and New Zealand (USANZ) in the issues the College raised.

“Ensuring surgeons have the ability to access what is required to successfully complete a case and obtain the best outcome must be of paramount concern in any reform. Funding must be adequate for the general use items without increasing contract disagreements between the payers and hospitals,” Professor Mark Frydenberg, Chair of Health Policy and Advocacy Committee, RACS said in the submission.

RACS has communicated with a number of stakeholders in the sector who have argued that the bundled benefits’ mandatory funding models proposed by the Department on the advice of IHACPA could have a number of undesirable impacts.  

“These potentially undesirable impacts include reduced availability of particular types of general use items, and hospitals restricting particular types of procedures, or even restricting particular clinicians who may use an above average number of general use items, due to cost pressures. Similar negative impacts have been predicted once the period during which mandatory bundled benefit payments ends on 1 July 2025,” Professor Frydenberg said in the submission.

RACS has been supportive of reforms to the PL which “improve the long-term sustainability and cost efficiency of healthcare”. 

However, the College recognised that there are likely to be clinicians who use unnecessary types or amounts of general use items.

“An appropriate reform would be to increase clinicians’ focus on choosing wisely in relation to such items, and prosthetic devices more generally. In principle RACS would be willing to work with regulators to educate surgeons and other clinicians about best practice in the use of such items and even provide opinions about different general use items and other disposables and prosthetics,” Professor Frydenberg said in the submission.

RACS is calling for an independent monitoring of procedures, and access to, and use of, devices removed from the PL, if the reforms continue as planned. Should monitoring find that clinicians believe their clinical choices have been significantly impacted, and/or should monitoring find that hospitals are restricting the procedures they provide due to these changes, then the changes should be revisited.  

In reimagining healthcare across the entire patient journey, Health Industry HubTM is the only one-stop-hub uniting the diversity of the Pharma, MedTech, Diagnostics & Biotech sectors to inspire meaningful change.

The Health Industry HubTM content is copyright protected. Access is available under individual user licenses. Please click here to subscribe and visit T&Cs here.


News & Trends - MedTech & Diagnostics

Government's claim of progress in genomics falls flat while it fails to uphold the fundamental rights of Aussies

Government’s claim of progress in genomics falls flat while it fails to uphold the fundamental rights of Aussies

Health Industry Hub | February 7, 2025 |

The government has unveiled Cancer Australia’s National Framework for Genomics in Cancer Control, a strategic plan designed to guide healthcare […]

More


News & Trends - Pharmaceuticals

Healthcare sector’s political donations: What to expect ahead of the federal election

Healthcare sector’s political donations: What to expect ahead of the federal election

Health Industry Hub | February 7, 2025 |

Ahead of the upcoming federal election, attention turns to the financial contributions to major political parties. The Australian Electoral Commission’s […]

More


News & Trends - Pharmaceuticals

'Underinvestment in gynae cancer has left critical gaps,' says ANZGOG Chair

‘Underinvestment in gynae cancer has left critical gaps,’ says ANZGOG Chair

Health Industry Hub | February 7, 2025 |

Ovarian cancer is the deadliest women’s cancer, with the latest statistics revealing a five-year survival rate of just 49%. Alarmingly, […]

More


News & Trends - MedTech & Diagnostics

Labor's one-off funding a band aid for public hospitals while private sector left in limbo

Labor’s one-off funding a band aid for public hospitals while private sector left in limbo

Health Industry Hub | February 6, 2025 |

The Federal Government has committed a one-off funding boost of $1.7 billion to public hospitals under a one-year extension to […]

More


This content is copyright protected. Please subscribe to gain access.